| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000032063 |
| Receipt No. | R000036576 |
| Scientific Title | A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial |
| Date of disclosure of the study information | 2018/05/01 |
| Last modified on | 2022/04/05 (Ver. 7) |
| Basic information | ||
| Public title | A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial | |
| Acronym | FINE project (Family pharmacist's Intervention for Nicotine Elimination) | |
| Scientific Title | A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial | |
| Scientific Title:Acronym | FINE project (Family pharmacist's Intervention for Nicotine Elimination) | |
| Region |
|
|
| Condition | ||
| Condition | Smokers | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the effect of the pharmacist-delivered smoking cessation program on smoking cessation in community pharmacies |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Carbon Monoxide-verified Abstinence or Color reaction of YANIKEN-verified Abstinence [ Time Frame: Week 12] |
| Key secondary outcomes | 1) Number of recommended cases to a smoking cessation clinic and visiting cases
2) Satisfaction score with pharmacist-delivered smoking cessation program 3) Recommendation score with pharmacist-delivered smoking cessation program |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1) Setting the target goal
2) Assessment and counseling for smoking cessation along with medication counseling 3) Telephone-delivered counseling 4) Giving information using support materials 5) Explanation and medication counseling of smoking cessation aids |
|
| Interventions/Control_2 | Usual care by pharmacist | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Person who taking medications
2) Person who are expected to visit community pharmacy over 8 weeks 3) Person who agree to receive smoking cessation program |
|||
| Key exclusion criteria | 1) Dementia or psychiatric disorders
2) Allergies or adverse effects with smoking cessation aids 3) Temporomandibular Joint Disorder (in the case of nicotine gum) 4) Pregnant women |
|||
| Target sample size | 84 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka University of Pharmaceutical Sciences | ||||||
| Division name | Department of Social and Administrative Pharmacy | ||||||
| Zip code | 569-1041 | ||||||
| Address | 4-20-1 Nasahara, Takatsuki, Osaka | ||||||
| TEL | +81-72-690-1059 | ||||||
| onda@gly.oups.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka University of Pharmaceutical Sciences | ||||||
| Division name | Department of Social and Administrative Pharmacy | ||||||
| Zip code | 569-1041 | ||||||
| Address | 4-20-1 Nasahara, Takatsuki, Osaka | ||||||
| TEL | +81-72-690-1059 | ||||||
| Homepage URL | |||||||
| onda@gly.oups.ac.jp | |||||||
| Sponsor | |
| Institute | Osaka University of Pharmaceutical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Osaka University of Pharmaceutical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka University of Pharmaceutical Sciences |
| Address | 4-20-1, Nasahara, Takatsuki, Osaka, Japan |
| Tel | +81-72-690-1103 |
| kenkyus@gly.oups.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://doi.org/10.1155/2021/9983515 | ||||||
| Number of participants that the trial has enrolled | 24 | ||||||
| Results | 572 smokers who met the eligibility criteria visited the target pharmacies. Of these, 24 patients agreed to participate in the study. Smoking cessation rates were 45.5% in the intervention group and 18.2% in the control group (P = 0:380, effect size = 0:60). | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Smokers aged 20 years or older who receive prescription medicines at pharmacies participating in the study and who are able to visit the pharmacy for a continuous period of three months | ||||||
| Participant flow | After receiving an explanation about the study from the pharmacist and agreeing to participate, participants received smoking cessation support through the FINE programme in the intervention group and usual support in the control group | ||||||
| Adverse events | No adverse events occurred during the study period. | ||||||
| Outcome measures | The primary endpoint was participants who had quit smoking at the end of the 3-month follow-up period (3-month quit rate). | ||||||
| Plan to share IPD | No data sharing plan for individual cases | ||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000036576 |